Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- LCT completes patient implants in Parkinson’s trial Read more →
- Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director Read more →
- Stem Cell Agency Board Approves $50 Million for CIRM 2.0, a “Radical Overhaul” of How it Drives Development of Stem Cell Treatments Read more →